Back to search

Article

Acceptability of newborn screening for Spinal Muscular Atrophy: views of the UK public, screened families, health professionals and SMA community

2026-02-23

Abstract excerpt

<title>Abstract</title> <p>With the advent of novel gene therapies, rare genetic diseases once lacking treatments are now being considered for newborn screening programmes (NBS). Indeed, Wilson and Jungner criteria (which are drawn on worldwide to guide screening programme evaluation) necessitate treatment availability for a recommendation of screening. Spinal muscular atrophy (SMA) is an example of a condition f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ea1b3665-37d2-5dc2-b0bf-051b1257f278
DOI
10.21203/rs.3.rs-8881933/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Acceptability of newborn screening for Spinal Muscular Atrophy: views of the UK public, screened families, health professionals and SMA communityDOI 10.21203/rs.3.rs-8881933/v1
Select a neighboring publication to make it the new centre.